Author
Listed:
- Natalia Voronina
(DKFZ
DKFZ
German Cancer Consortium (DKTK))
- John K. L. Wong
(DKFZ
German Cancer Consortium (DKTK))
- Daniel Hübschmann
(German Cancer Consortium (DKTK)
DKFZ
Heidelberg Institute for Stem cell Technology and Experimental Medicine (HI-STEM)
Heidelberg University Hospital)
- Mario Hlevnjak
(DKFZ
DKFZ)
- Sebastian Uhrig
(DKFZ
DKFZ and NCT Heidelberg
Heidelberg University)
- Christoph E. Heilig
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Peter Horak
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Simon Kreutzfeldt
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Andreas Mock
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Albrecht Stenzinger
(Heidelberg University Hospital)
- Barbara Hutter
(DKFZ
DKFZ and NCT Heidelberg)
- Martina Fröhlich
(DKFZ
DKFZ and NCT Heidelberg)
- Benedikt Brors
(DKFZ and NCT Heidelberg)
- Arne Jahn
(German Cancer Consortium (DKTK)
German Cancer Research Center (DKFZ)
National Center for Tumor Diseases (NCT)
NCT Dresden, Dresden, and DKFZ)
- Barbara Klink
(German Cancer Consortium (DKTK)
German Cancer Research Center (DKFZ)
National Center for Tumor Diseases (NCT)
National Center of Genetics (NCG), Laboratoire national de santé (LNS))
- Laura Gieldon
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Lina Sieverling
(DKFZ and NCT Heidelberg)
- Lars Feuerbach
(DKFZ and NCT Heidelberg)
- Priya Chudasama
(DKFZ, National Center for Tumor (NCT) Diseases)
- Katja Beck
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Matthias Kroiss
(University Hospital Würzburg)
- Christoph Heining
(NCT Dresden, Dresden, and DKFZ
University Hospital Carl Gustav Carus Dresden, Technical University of Dresden
German Cancer Consortium (DKTK))
- Lino Möhrmann
(NCT Dresden, Dresden, and DKFZ
University Hospital Carl Gustav Carus Dresden, Technical University of Dresden
German Cancer Consortium (DKTK))
- Andrea Fischer
(German Cancer Consortium (DKTK)
German Cancer Research Center (DKFZ)
National Center for Tumor Diseases (NCT))
- Evelin Schröck
(German Cancer Consortium (DKTK)
German Cancer Research Center (DKFZ)
National Center for Tumor Diseases (NCT))
- Hanno Glimm
(NCT Dresden, Dresden, and DKFZ
University Hospital Carl Gustav Carus Dresden, Technical University of Dresden
German Cancer Consortium (DKTK))
- Marc Zapatka
(DKFZ
German Cancer Consortium (DKTK))
- Peter Lichter
(DKFZ
German Cancer Consortium (DKTK))
- Stefan Fröhling
(German Cancer Consortium (DKTK)
National Center for Tumor Diseases (NCT) Heidelberg and DKFZ
DKFZ-Heidelberg Center for Personalized Oncology (HIPO))
- Aurélie Ernst
(DKFZ
DKFZ
German Cancer Consortium (DKTK))
Abstract
Chromothripsis is a recently identified mutational phenomenon, by which a presumably single catastrophic event generates extensive genomic rearrangements of one or a few chromosome(s). Considered as an early event in tumour development, this form of genome instability plays a prominent role in tumour onset. Chromothripsis prevalence might have been underestimated when using low-resolution methods, and pan-cancer studies based on sequencing are rare. Here we analyse chromothripsis in 28 tumour types covering all major adult cancers (634 tumours, 316 whole-genome and 318 whole-exome sequences). We show that chromothripsis affects a substantial proportion of human cancers, with a prevalence of 49% across all cases. Chromothripsis generates entity-specific genomic alterations driving tumour development, including clinically relevant druggable fusions. Chromothripsis is linked with specific telomere patterns and univocal mutational signatures in distinct tumour entities. Longitudinal analysis of chromothriptic patterns in 24 matched tumour pairs reveals insights in the clonal evolution of tumours with chromothripsis.
Suggested Citation
Natalia Voronina & John K. L. Wong & Daniel Hübschmann & Mario Hlevnjak & Sebastian Uhrig & Christoph E. Heilig & Peter Horak & Simon Kreutzfeldt & Andreas Mock & Albrecht Stenzinger & Barbara Hutter , 2020.
"The landscape of chromothripsis across adult cancer types,"
Nature Communications, Nature, vol. 11(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16134-7
DOI: 10.1038/s41467-020-16134-7
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Qing Hu & Jose Espejo Valle-Inclán & Rashmi Dahiya & Alison Guyer & Alice Mazzagatti & Elizabeth G. Maurais & Justin L. Engel & Huiming Lu & Anthony J. Davis & Isidro Cortés-Ciriano & Peter Ly, 2024.
"Non-homologous end joining shapes the genomic rearrangement landscape of chromothripsis from mitotic errors,"
Nature Communications, Nature, vol. 15(1), pages 1-13, December.
- Xue-Ke Zhao & Pengwei Xing & Xin Song & Miao Zhao & Linxuan Zhao & Yonglong Dang & Ling-Ling Lei & Rui-Hua Xu & Wen-Li Han & Pan-Pan Wang & Miao-Miao Yang & Jing-Feng Hu & Kan Zhong & Fu-You Zhou & Xu, 2021.
"Focal amplifications are associated with chromothripsis events and diverse prognoses in gastric cardia adenocarcinoma,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
- Hanna Braun & Ziyan Xu & Fiona Chang & Nikenza Viceconte & Grishma Rane & Michal Levin & Liudmyla Lototska & Franziska Roth & Alexia Hillairet & Albert Fradera-Sola & Vartika Khanchandani & Zi Wayne S, 2023.
"ZNF524 directly interacts with telomeric DNA and supports telomere integrity,"
Nature Communications, Nature, vol. 14(1), pages 1-17, December.
- Yoshitaka Sakamoto & Shuhei Miyake & Miho Oka & Akinori Kanai & Yosuke Kawai & Satoi Nagasawa & Yuichi Shiraishi & Katsushi Tokunaga & Takashi Kohno & Masahide Seki & Yutaka Suzuki & Ayako Suzuki, 2022.
"Phasing analysis of lung cancer genomes using a long read sequencer,"
Nature Communications, Nature, vol. 13(1), pages 1-17, December.
- Vázquez López, Raul, 2023.
"La competitividad de las exportaciones del sector químico mexicano en los Estados Unidos de América y la Unión Europea, 1994-2015,"
Apuntes del Cenes, Universidad Pedagógica y Tecnológica de Colombia, vol. 42(75), pages 83-109, January.
- Feifei Xie & Shuzhen Luo & Dongbing Liu & Xiaojing Lu & Ming Wang & Xiaoxiao Liu & Fujian Jia & Yuzhi Pang & Yanying Shen & Chunling Zeng & Xinli Ma & Daoqiang Tang & Lin Tu & Linxi Yang & Yumei Cheng, 2024.
"Genomic and transcriptomic landscape of human gastrointestinal stromal tumors,"
Nature Communications, Nature, vol. 15(1), pages 1-20, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16134-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.